Belmora Flanax Tablet
Product Images NDC 27854-555

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Belmora Flanax (NDC 27854-555). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Belmora Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Belmora (Belmora Flanax Marksans Label 7 9 20)

Drug Facts panel for Belmora Flanax 220 mg Naproxen Sodium tablets. It includes active ingredient and purpose, uses, warnings, directions for adults and children, and other product information such as storage and inactive ingredients. The label also highlights longer lasting pain relief for minor aches and pains such as headache, backache, arthritis, fever, menstrual cramps, toothache, and common cold.*

FDA Label Image

Drug Facts

Drug Facts label for Belmora Flanax Naproxen Sodium 220 mg tablets. The label includes active ingredient information, uses, warnings, directions, inactive ingredients, and additional safety information. It covers allergy warnings, stomach bleeding warnings, heart attack and stroke warnings, drug interactions, and proper dosage instructions. Contact information for questions is also provided.*

FDA Label Image

Flanax 24ct Carton Marksans Proof Final

Belmora Flanax 220 mg oral tablets packaging label for naproxen sodium, a pain reliever and fever reducer. The label displays the brand name FLANAX prominently, along with dosing information for 12-hour pain relief. The packaging is predominantly blue with white and red accents, showing a human figure highlighting pain areas. The label includes Drug Facts and directions in both English and Spanish. Distributed by Belmora LLC.*

FDA Label Image

Af5e42f7 D165 0af1 E053 2995a90ac09b

Belmora Flanax 220 mg tablet, round and light blue, imprinted with '141' on one side. The tablet is oral dosage form containing the active ingredient naproxen sodium, manufactured by Belmora LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.